The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.00
Bid: 18.00
Ask: 20.00
Change: 0.00 (0.00%)
Spread: 2.00 (11.111%)
Open: 19.00
High: 19.00
Low: 19.00
Prev. Close: 19.00
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New patent grants

23 May 2019 07:00

RNS Number : 9202Z
Directa Plus PLC
23 May 2019
 

23 May 2019

 

Directa Plus plc

("Directa Plus" or the "Company")

 

New patent grants

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene-based products for use in consumer and industrial markets, is pleased to announce that the Company has been granted two new patents, for the application of the Company's G+ graphene products.

 

Graphene enhanced golf balls

 

The first is an Italian patent for the use of the Company's G+ graphene in the manufacture of golf balls. The use of the G+ compounds in golf balls, can provide a series of beneficial features that offer opportunities to develop a new generation of golf ball, both for professional and amateur players.

 

Certain G+ compounds will be able to achieve particular qualities when added to golf balls.

 

G+ materials can be used to enhance the hard core of professional golf balls in order to increase the shot distance potential of the ball, without losing lateral control. In addition, G+ can be used in the amateur golf ball market, to guarantee swing and improved control.

 

Preparing Graphene Nanoplatelets

 

The second is a Chinese patent, covering Directa Plus' unique process for the manufacturing graphene nanoplatelets.

Directa Plus's unique exfoliation technology is chemical free, has an extremely high yield, and can be varied to produce graphene nanoplatelets with specific morphologies. This means that G+ products are safe for human health, can be tailor-made to meet customers' needs, and the high-yields create competitive prices.

Additionally, the unique characteristics of the G+ process, allow the Company to enter large supply chains, in turn overcoming important entry barriers into the market.

 

Commenting on the agreement, Giulio Cesareo, Founder and CEO of Directa Plus, said:

 

"I'm very pleased that we were able to secure two new patents. We continue to show how our G+ graphene nanoplatelets can enhance products in various categories, and it is vital that we secure the Intellectual Property rights needed to protect our unique technology in worldwide jurisdictions.

 

"Securing Intellectual Property rights for our technological innovations is a key part of our corporate strategy - across global jurisdictions. The Company's current suite of patents now includes 22 granted, and a further 22 pending approval."

 

"Using our G+ product in golf balls, for both the amateur and professional game is an exciting opportunity to enter a large sporting market. "

 

"Additionally, gaining legal recognition of the Company's proprietary, chemical-free graphene production process in China will allow us to enter into larger Chinese supply chains more easily and overcome these barriers in the future."

 

 

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

 

 

Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)

+44 20 7894 7000

Rick Thompson, Philip Davies Will Goode (Corporate Finance)

 

Caspar Shand Kydd (Sales)

 

 

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Mark Taylor, Lauren Kettle

 

 

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson, Barnaby Hayward, Edward Lee

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRASEEEEEFUSEFI
Date   Source Headline
31st Jul 20187:00 amRNSAppointment of N+1 Singer as Joint Broker
9th Jul 201810:00 amRNSOakley and Bioracer launch Graphene Plus jersey
4th Jul 20187:00 amRNSSecond significant order from Alfredo Grassi
18th Jun 20184:28 pmRNSResult of AGM
18th Jun 20187:00 amRNSAGM Statement
1st Jun 20187:00 amRNSTransfer in Significant Shareholding
25th May 20187:00 amRNSNotice of AGM
14th May 20187:00 amRNSExclusive Collaboration Agreement with Arvind
2nd May 20181:06 pmRNSDirector Share Purchase
1st May 201810:56 amRNSDirector Share Purchase
30th Apr 20187:00 amRNSAgreement with Global Leader in Luxury Accessories
26th Apr 20187:00 amRNSDirectorate Change
26th Apr 20187:00 amRNSFinal Results
23rd Apr 20187:00 amRNSStrategic Collaboration with Marangoni Group
9th Apr 20188:25 amRNSSuccessful Grafysorber® field test with OMV Petrom
21st Mar 20187:00 amRNSSartec agreement to commercialise Grafysorber®
19th Feb 20187:00 amRNSPatent for G+ elastomeric composition for tyres
6th Feb 20187:07 amRNSColmar and Eurojersey launch new G+ collections
24th Jan 20187:00 amRNSUS patent for graphene flame-retardant composition
15th Jan 20187:00 amRNSPre-Close Trading Update
21st Dec 20177:00 amRNSOrder from Vittoria
14th Dec 20177:00 amRNSCollaboration with GSP SA on Grafysorber®
23rd Nov 20177:00 amRNSDirecta Plus and Iterchimica develop Eco Pave
14th Nov 20177:00 amRNSG+ textiles certified as 'non-irritating'
11th Oct 201712:27 pmRNSDirector/PDMR Shareholding
10th Oct 20171:13 pmRNSPDMR Shareholding
28th Sep 20177:01 amRNSContract with Alfredo Grassi to supply G+ graphene
28th Sep 20177:00 amRNSInterim Results
21st Aug 20177:00 amRNSAppointment of Luca Provolo as Head of Sales
3rd Aug 20174:35 pmRNSPrice Monitoring Extension
22nd Jun 20177:00 amRNSDirecta Plus collaboration with Alfredo Grassi
7th Jun 20173:54 pmRNSResult of AGM
7th Jun 20172:22 pmRNSAGM Statement
25th May 201710:46 amRNSDirector Dealing
12th May 20177:00 amRNSAnnual Report Posting, AGM Notice & Options Grant
9th May 201711:05 amRNSDirector/PDMR Shareholding
5th May 20177:00 amRNSDirector Dealing
4th May 201710:47 amRNSDealing by Proposed Director
4th May 20177:00 amRNSDirector/PDMR Shareholding
28th Apr 201711:00 amRNSPrice Monitoring Extension
28th Apr 20179:50 amRNSDirectorate Changes
28th Apr 20177:00 amRNSFinal Results
20th Feb 20177:00 amRNSGrant Award for Textiles Project
2nd Dec 20167:00 amRNSCustomer Announcement
22nd Nov 20167:00 amRNSDirecta Plus Achieves ISO 14001:2015 Certification
14th Nov 20167:00 amRNSAcquisition and Directa Textile Solutions launch
18th Oct 20167:01 amRNSFurther two patents granted
18th Oct 20167:00 amRNSCustomer announcement
21st Sep 20167:00 amRNSInterim Results
15th Sep 201610:30 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.